![Anthony P. Jansz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anthony P. Jansz
Direktor/Vorstandsmitglied bei The Medical Finance Co.
Aktive Positionen von Anthony P. Jansz
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
The Medical Finance Co. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Anthony P. Jansz
Ehemalige bekannte Positionen von Anthony P. Jansz
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
EnteroMedics, Inc.
![]() EnteroMedics, Inc. Medical SpecialtiesHealth Technology EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN. | Direktor/Vorstandsmitglied | 11.05.2011 | 12.08.2016 |
Independent Dir/Board Member | 01.05.2011 | 14.04.2015 | |
The Australian Institute of Weight Control | Vorsitzender | 01.03.2011 | 01.03.2011 |
THE CARLYLE GROUP INC. | Corporate Officer/Principal | 01.01.2000 | 01.01.2005 |
Statistik
International
Vereinigte Staaten | 3 |
Australien | 3 |
Operativ
Director/Board Member | 2 |
Independent Dir/Board Member | 1 |
Chairman | 1 |
Sektoral
Health Technology | 2 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
THE CARLYLE GROUP INC. | Finance |
Private Unternehmen | 3 |
---|---|
EnteroMedics, Inc.
![]() EnteroMedics, Inc. Medical SpecialtiesHealth Technology EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN. | Health Technology |
The Australian Institute of Weight Control | |
The Medical Finance Co. |
- Börse
- Insiders
- Anthony P. Jansz
- Erfahrung